Skip to main content
OpenTrials

Clinical trial condition

Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Explore clinical trials studying Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia trial results

Recruiting

Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

NCT07074496

Conditions
Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
Locations
  • The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology Suzhou, Jiangsu, China
  • The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology Suzhou, Jiangsu, China
View Trial Details
Completed

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

NCT02081378

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +13 more
Locations
  • Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering New York, United States
  • Oregon Health Sciences University SC-6 Portland, Oregon, United States
View all 18 locations
View Trial Details
Completed

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

NCT03647215

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +20 more
Locations
  • Limerick University Hospital Limerick, Dooradoyle, Ireland
  • University Hospital Waterford Waterford, Ireland
  • Royal Cornwall Hospital Truro, Cornwall, United Kingdom
  • Royal Devon & Exeter Hospital Exeter, Devon, United Kingdom
View all 33 locations
View Trial Details

Related conditions